S. Digiambenedetto

Variability of Raltegravir Plasma Levels in the Clinical Setting

L. Lisi, P. Navarra, M. Fabbiani, 2013, Pharmacology.

Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort).

S. Leone, S. Lo Caputo, F. Mazzotta, 2015, International journal of epidemiology.

Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy.

M. Prosperi, I. Frank, C. Torti, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Systemic Inflammation-Based Biomarkers and Survival in HIV-Positive Subject With Solid Cancer in an Italian Multicenter Study

F. Donato, F. Castelli, A. Bandera, 2015, Journal of acquired immune deficiency syndromes.

Systemic inflammation-based scores and mortality for all causes in HIV-infected patients: a MASTER cohort study

F. Donato, A. Bandera, E. Raffetti, 2017, BMC Infectious Diseases.

The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort study

F. Donato, F. Castelli, A. Bandera, 2015, Journal of Translational Medicine.

Is Dolutegravir Plus Atazanavir Overburdened With Concentration-Related Neurological Events Compared With Other Dual Regimens?

G. Rizzardini, A. Capetti, S. Digiambenedetto, 2019, Open forum infectious diseases.